Market Overview:
The global antibiotics active pharmaceutical ingredient (API) market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of infectious diseases, growing demand for generic drugs, and rising investments by pharmaceutical companies in R&D activities. Based on type, the antibiotics API market is segmented into penicillin antibiotics, cephalosporins, and carbapenem antibiotics. The penicillin antibiotic segment is expected to account for the largest share of the global antibiotics API market in 2018. This segment is also projected to grow at a CAGR of 6.8% during the forecast period from 2018 to 2030.
Product Definition:
The term antibiotic is derived from the Latin words anti (against) and bios (life). Antibiotics are drugs that kill or inhibit the growth of bacteria. They are used to treat infections caused by bacteria. The most common use of antibiotics is to treat bacterial infections in humans, such as pneumonia, strep throat, and urinary tract infections. Antibiotics are also used to treat diseases in animals, such as mastitis (an infection of the mammary gland) and foot rot (a bacterial infection of the feet).
The importance of antibiotics cannot be overstated. Without them, many common illnesses would be fatal.
Penicillin Antibiotics:
Penicillin antibiotics are a group of drugs derived from Penicillium fungi. These fungi grow in the absence of light on rich nutrient media and contain penicillin when culturing. The most commonly used species for production of penicillin antibiotics is P. chrysogenum, although other species such as P. brenneum, P.
Cephalosporins:
Cephalosporins are a group of antibiotics that inhibit the bacterial protein synthesis. They are used in the treatment of various bacterial infections, such as pneumonia, skin and soft tissue infections, gonorrhea and ear infection. Cephalosporin can be administered with other drugs to treat diseases like tuberculosis (TB), Lyme disease and leprosy.
Application Insights:
The global antibiotics active pharmaceutical ingredient market is segmented by application into pharmaceutical companies, contract manufacturing organizations (CMOs), contract development and manufacturing organizations (CDMO) and others. The other applications include hospitals, clinics, veterinary medicine and agriculture. The agricultural use of antibiotics was one of the major drivers for this market as it is used to treat livestock diseases globally. However, there has been a rise in the awareness about its adverse effects on human health due to overuse which has led to a decline in its consumption in this sector.
The pharmaceutical companies segment held around 60% of the overall revenue share in 2017 owing to high usage across various therapeutic areas such as respiratory infections, skin infections & wounds/abrasions etc., bacterial meningitis & sepsis etc., viral infections like chickenpox & measles etc., fungal infections like athlete¢â‚¬â„¢s foot & yeast infection etc.
Regional Analysis:
Asia Pacific dominated the global market in 2017, with a share of over 57.0% and is anticipated to witness significant growth during the forecast period. The presence of key pharmaceutical companies such as Gilead Sciences, FUJIFILM Diosynth Biotechnologies Corporation, Novartis AG and many others are based in this region is one of the major factors responsible for its dominance. These companies are engaged in R&D activities to identify potential antibiotics targets and develop novel therapeutics for various diseases including antibiotic-resistant infections that have created a need for global antibiotic active ingredients market.
Growth Factors:
- Increasing incidence of infectious diseases: The increasing incidence of infectious diseases is one of the major growth drivers for the antibiotics active pharmaceutical ingredient market. This is because infections caused by bacteria are becoming increasingly resistant to antibiotics, which has led to an increase in the demand for antibiotics active pharmaceutical ingredients.
- Rising awareness about antibiotic resistance: There is a growing awareness among people about antibiotic resistance and its implications on human health. This is leading to an increased demand for effective antibiotics, which in turn is driving the growth of the antibiotics active pharmaceutical ingredient market.
- Growing prevalence of lifestyle-related diseases: The growing prevalence of lifestyle-related diseases such as obesity and diabetes has led to an increase in the number of patients susceptible to bacterial infections. This is fueling demand for effective antibiotics, thereby propelling growth of the global market for antibiotics active pharmaceutical ingredients.
Scope Of The Report
Report Attributes
Report Details
Report Title
Antibiotics Active Pharmaceutical Ingredient Market Research Report
By Type
Penicillin Antibiotics, Cephalosporins, Carbapenem Antibiotics
By Application
Pharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Development & Manufacturing Organizations (CDMOs)
By Companies
Sandoz International, Centrient Pharmaceuticals, CordenPharma International, ACS DOBFAR, Nanjing Dorra Pharmaceutical Technology, DAEWOONG PHARMACEUTICAL, Parabolic Drugs, Penam Laboratories, ASIATIC DRUGS & PHARMACEUTICALS, Fresenius Kabi, The United Laboratories International Holdings, Aurobindo Pharma Limited, Unimark Remedies, Savior Lifetec
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
202
Number of Tables & Figures
142
Customization Available
Yes, the report can be customized as per your need.
Global Antibiotics Active Pharmaceutical Ingredient Market Report Segments:
The global Antibiotics Active Pharmaceutical Ingredient market is segmented on the basis of:
Types
Penicillin Antibiotics, Cephalosporins, Carbapenem Antibiotics
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Development & Manufacturing Organizations (CDMOs)
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sandoz International
- Centrient Pharmaceuticals
- CordenPharma International
- ACS DOBFAR
- Nanjing Dorra Pharmaceutical Technology
- DAEWOONG PHARMACEUTICAL
- Parabolic Drugs
- Penam Laboratories
- ASIATIC DRUGS & PHARMACEUTICALS
- Fresenius Kabi
- The United Laboratories International Holdings
- Aurobindo Pharma Limited
- Unimark Remedies
- Savior Lifetec
Highlights of The Antibiotics Active Pharmaceutical Ingredient Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Penicillin Antibiotics
- Cephalosporins
- Carbapenem Antibiotics
- By Application:
- Pharmaceutical Companies
- Contract Manufacturing Organizations (CMOs)
- Contract Development & Manufacturing Organizations (CDMOs)
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Antibiotics Active Pharmaceutical Ingredient Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Antibiotics are active pharmaceutical ingredients (API) that are used to treat infections.
Some of the major players in the antibiotics active pharmaceutical ingredient market are Sandoz International, Centrient Pharmaceuticals, CordenPharma International, ACS DOBFAR, Nanjing Dorra Pharmaceutical Technology, DAEWOONG PHARMACEUTICAL, Parabolic Drugs, Penam Laboratories, ASIATIC DRUGS & PHARMACEUTICALS, Fresenius Kabi, The United Laboratories International Holdings, Aurobindo Pharma Limited, Unimark Remedies, Savior Lifetec.
The antibiotics active pharmaceutical ingredient market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Antibiotics Active Pharmaceutical Ingredient Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Antibiotics Active Pharmaceutical Ingredient Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Antibiotics Active Pharmaceutical Ingredient Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Antibiotics Active Pharmaceutical Ingredient Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Antibiotics Active Pharmaceutical Ingredient Market Size & Forecast, 2018-2028
4.5.1 Antibiotics Active Pharmaceutical Ingredient Market Size and Y-o-Y Growth
4.5.2 Antibiotics Active Pharmaceutical Ingredient Market Absolute $ Opportunity
Chapter 5 Global Antibiotics Active Pharmaceutical Ingredient Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Antibiotics Active Pharmaceutical Ingredient Market Size Forecast by Type
5.2.1 Penicillin Antibiotics
5.2.2 Cephalosporins
5.2.3 Carbapenem Antibiotics
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Antibiotics Active Pharmaceutical Ingredient Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Antibiotics Active Pharmaceutical Ingredient Market Size Forecast by Applications
6.2.1 Pharmaceutical Companies
6.2.2 Contract Manufacturing Organizations (CMOs)
6.2.3 Contract Development & Manufacturing Organizations (CDMOs)
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Antibiotics Active Pharmaceutical Ingredient Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Antibiotics Active Pharmaceutical Ingredient Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Antibiotics Active Pharmaceutical Ingredient Analysis and Forecast
9.1 Introduction
9.2 North America Antibiotics Active Pharmaceutical Ingredient Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Antibiotics Active Pharmaceutical Ingredient Market Size Forecast by Type
9.6.1 Penicillin Antibiotics
9.6.2 Cephalosporins
9.6.3 Carbapenem Antibiotics
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Antibiotics Active Pharmaceutical Ingredient Market Size Forecast by Applications
9.10.1 Pharmaceutical Companies
9.10.2 Contract Manufacturing Organizations (CMOs)
9.10.3 Contract Development & Manufacturing Organizations (CDMOs)
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Antibiotics Active Pharmaceutical Ingredient Analysis and Forecast
10.1 Introduction
10.2 Europe Antibiotics Active Pharmaceutical Ingredient Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Antibiotics Active Pharmaceutical Ingredient Market Size Forecast by Type
10.6.1 Penicillin Antibiotics
10.6.2 Cephalosporins
10.6.3 Carbapenem Antibiotics
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Antibiotics Active Pharmaceutical Ingredient Market Size Forecast by Applications
10.10.1 Pharmaceutical Companies
10.10.2 Contract Manufacturing Organizations (CMOs)
10.10.3 Contract Development & Manufacturing Organizations (CDMOs)
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Antibiotics Active Pharmaceutical Ingredient Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Antibiotics Active Pharmaceutical Ingredient Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Antibiotics Active Pharmaceutical Ingredient Market Size Forecast by Type
11.6.1 Penicillin Antibiotics
11.6.2 Cephalosporins
11.6.3 Carbapenem Antibiotics
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Antibiotics Active Pharmaceutical Ingredient Market Size Forecast by Applications
11.10.1 Pharmaceutical Companies
11.10.2 Contract Manufacturing Organizations (CMOs)
11.10.3 Contract Development & Manufacturing Organizations (CDMOs)
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Antibiotics Active Pharmaceutical Ingredient Analysis and Forecast
12.1 Introduction
12.2 Latin America Antibiotics Active Pharmaceutical Ingredient Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Antibiotics Active Pharmaceutical Ingredient Market Size Forecast by Type
12.6.1 Penicillin Antibiotics
12.6.2 Cephalosporins
12.6.3 Carbapenem Antibiotics
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Antibiotics Active Pharmaceutical Ingredient Market Size Forecast by Applications
12.10.1 Pharmaceutical Companies
12.10.2 Contract Manufacturing Organizations (CMOs)
12.10.3 Contract Development & Manufacturing Organizations (CDMOs)
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Antibiotics Active Pharmaceutical Ingredient Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Antibiotics Active Pharmaceutical Ingredient Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Antibiotics Active Pharmaceutical Ingredient Market Size Forecast by Type
13.6.1 Penicillin Antibiotics
13.6.2 Cephalosporins
13.6.3 Carbapenem Antibiotics
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Antibiotics Active Pharmaceutical Ingredient Market Size Forecast by Applications
13.10.1 Pharmaceutical Companies
13.10.2 Contract Manufacturing Organizations (CMOs)
13.10.3 Contract Development & Manufacturing Organizations (CDMOs)
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Antibiotics Active Pharmaceutical Ingredient Market: Competitive Dashboard
14.2 Global Antibiotics Active Pharmaceutical Ingredient Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sandoz International
14.3.2 Centrient Pharmaceuticals
14.3.3 CordenPharma International
14.3.4 ACS DOBFAR
14.3.5 Nanjing Dorra Pharmaceutical Technology
14.3.6 DAEWOONG PHARMACEUTICAL
14.3.7 Parabolic Drugs
14.3.8 Penam Laboratories
14.3.9 ASIATIC DRUGS & PHARMACEUTICALS
14.3.10 Fresenius Kabi
14.3.11 The United Laboratories International Holdings
14.3.12 Aurobindo Pharma Limited
14.3.13 Unimark Remedies
14.3.14 Savior Lifetec
